Lan Hoang-Minh

744 total citations
21 papers, 383 citations indexed

About

Lan Hoang-Minh is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Lan Hoang-Minh has authored 21 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Oncology. Recurrent topics in Lan Hoang-Minh's work include Genetic and Kidney Cyst Diseases (5 papers), CAR-T cell therapy research (4 papers) and Glioma Diagnosis and Treatment (4 papers). Lan Hoang-Minh is often cited by papers focused on Genetic and Kidney Cyst Diseases (5 papers), CAR-T cell therapy research (4 papers) and Glioma Diagnosis and Treatment (4 papers). Lan Hoang-Minh collaborates with scholars based in United States, Mexico and Germany. Lan Hoang-Minh's co-authors include Duane A. Mitchell, Matthew R. Sarkisian, Loic P. Deleyrolle, Brent A. Reynolds, Carlos Rinaldi, Joshua J. Breunig, Andreina Chiu‐Lam, Marina Dutra‐Clarke, Susan L. Semple‐Rowland and Regina T. Martuscello and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Lan Hoang-Minh

21 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Hoang-Minh United States 11 223 134 77 71 66 21 383
Irena Koutná Czechia 17 550 2.5× 120 0.9× 39 0.5× 57 0.8× 83 1.3× 52 699
Polly J. Phillips‐Mason United States 14 392 1.8× 74 0.6× 96 1.2× 42 0.6× 93 1.4× 18 543
Gro Oddveig Ness Norway 10 163 0.7× 103 0.8× 27 0.4× 29 0.4× 84 1.3× 16 416
Sue J. Hong United States 4 299 1.3× 56 0.4× 45 0.6× 40 0.6× 177 2.7× 11 466
Ashley Woods United States 10 290 1.3× 62 0.5× 88 1.1× 97 1.4× 210 3.2× 17 543
Anghara Menéndez Spain 8 256 1.1× 127 0.9× 71 0.9× 73 1.0× 71 1.1× 13 471
Zulekha A. Qadeer United States 8 497 2.2× 71 0.5× 44 0.6× 34 0.5× 84 1.3× 8 621
Jeff Chi‐feng Hsu United States 9 182 0.8× 37 0.3× 55 0.7× 57 0.8× 70 1.1× 11 362
Juri Kiyokawa United States 11 152 0.7× 126 0.9× 92 1.2× 26 0.4× 183 2.8× 18 405
Akane Yamamichi Japan 12 147 0.7× 48 0.4× 108 1.4× 90 1.3× 221 3.3× 25 400

Countries citing papers authored by Lan Hoang-Minh

Since Specialization
Citations

This map shows the geographic impact of Lan Hoang-Minh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Hoang-Minh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Hoang-Minh more than expected).

Fields of papers citing papers by Lan Hoang-Minh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Hoang-Minh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Hoang-Minh. The network helps show where Lan Hoang-Minh may publish in the future.

Co-authorship network of co-authors of Lan Hoang-Minh

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Hoang-Minh. A scholar is included among the top collaborators of Lan Hoang-Minh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Hoang-Minh. Lan Hoang-Minh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Changlin, Christina A. Von Roemeling, Lan Hoang-Minh, et al.. (2024). mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors. Genome Medicine. 16(1). 17–17. 28 indexed citations
2.
Roemeling, Christina A. Von, Changlin Yang, Bently P. Doonan, et al.. (2024). Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade. Nature Communications. 15(1). 5871–5871. 5 indexed citations
3.
Roemeling, Christina A. Von, Bently P. Doonan, Lan Hoang-Minh, et al.. (2023). Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases. Clinical Cancer Research. 29(9). 1751–1762. 15 indexed citations
4.
Hwang, Eugene, Elias Sayour, Catherine Flores, et al.. (2022). The current landscape of immunotherapy for pediatric brain tumors. Nature Cancer. 3(1). 11–24. 34 indexed citations
5.
Doonan, Bently P., et al.. (2022). DDDR-04. CA-4948 IN COMBINATION WITH BRAF/MEK INHIBITION IN MELANOMA BRAIN METASTASES. Neuro-Oncology. 24(Supplement_7). vii99–vii99. 1 indexed citations
6.
Roemeling, Christina A. Von, et al.. (2022). 1111 Immune modulation of melanoma brain metastases by IRAK-4 inhibition. Regular and Young Investigator Award Abstracts. A1154–A1154. 1 indexed citations
7.
Roemeling, Christina A. Von, et al.. (2022). P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA. HemaSphere. 6. 1183–1184. 2 indexed citations
8.
Doonan, Bently P., et al.. (2022). CA-4948 for the treatment of melanoma brain metastasis.. Journal of Clinical Oncology. 40(16_suppl). 2011–2011. 1 indexed citations
9.
Hoang-Minh, Lan, et al.. (2021). Tracking adoptive T cell immunotherapy using magnetic particle imaging. Nanotheranostics. 5(4). 431–444. 73 indexed citations
10.
Hoang-Minh, Lan, Jia Tian, Alice Cheng, et al.. (2021). HDAC6 Signaling at Primary Cilia Promotes Proliferation and Restricts Differentiation of Glioma Cells. Cancers. 13(7). 1644–1644. 22 indexed citations
11.
Roemeling, Christina A. Von, Lan Hoang-Minh, Bently P. Doonan, Chenglong Li, & Duane A. Mitchell. (2021). EXTH-08. STAT3 AT THE CROSSROADS OF INNATE IMMUNE ACTIVATION IN GLIOBLASTOMA. Neuro-Oncology. 23(Supplement_6). vi164–vi165. 1 indexed citations
12.
Hoang-Minh, Lan, et al.. (2020). RNA-electroporated T cells for cancer immunotherapy. OncoImmunology. 9(1). 1792625–1792625. 9 indexed citations
13.
Hoang-Minh, Lan, et al.. (2019). IMMU-25. MAGNETIC PARTICLE IMAGING FOR NON-INVASIVE TRACKING OF ADOPTIVE CELL TRANSFER IN CANCER IMMUNOTHERAPY. Neuro-Oncology. 21(Supplement_6). vi124–vi124. 1 indexed citations
14.
Hoang-Minh, Lan & Duane A. Mitchell. (2018). Immunotherapy for Brain Tumors. Current Treatment Options in Oncology. 19(11). 60–60. 15 indexed citations
15.
Hoang-Minh, Lan, Marina Dutra‐Clarke, Joshua J. Breunig, & Matthew R. Sarkisian. (2018). Glioma cell proliferation is enhanced in the presence of tumor-derived cilia vesicles. SHILAP Revista de lepidopterología. 7(1). 6–6. 32 indexed citations
16.
Hoang-Minh, Lan, et al.. (2016). PCM1 Depletion Inhibits Glioblastoma Cell Ciliogenesis and Increases Cell Death and Sensitivity to Temozolomide. Translational Oncology. 9(5). 392–402. 48 indexed citations
17.
Hoang-Minh, Lan, Loic P. Deleyrolle, Dorit Siebzehnrubl, et al.. (2016). Disruption of KIF3A in patient-derived glioblastoma cells: effects on ciliogenesis, hedgehog sensitivity, and tumorigenesis. Oncotarget. 7(6). 7029–7043. 24 indexed citations
18.
Smith, Tyler S., et al.. (2016). Neonatal seizures induced by pentylenetetrazol or kainic acid disrupt primary cilia growth on developing mouse cortical neurons. Experimental Neurology. 282. 119–127. 16 indexed citations
19.
Sarkisian, Matthew R., Dorit Siebzehnrubl, Lan Hoang-Minh, et al.. (2014). Detection of primary cilia in human glioblastoma. Journal of Neuro-Oncology. 117(1). 15–24. 47 indexed citations
20.
Hoang-Minh, Lan, et al.. (2012). Enzymatic digestion improves the purity of harvested cerebral microvessels. Journal of Neuroscience Methods. 207(1). 80–85. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irena Koutná Breakdown of academic impact, for papers by Polly J. Phillips‐Mason Breakdown of academic impact, for papers by Gro Oddveig Ness Breakdown of academic impact, for papers by Sue J. Hong Breakdown of academic impact, for papers by Ashley Woods Breakdown of academic impact, for papers by Anghara Menéndez Breakdown of academic impact, for papers by Zulekha A. Qadeer Breakdown of academic impact, for papers by Jeff Chi‐feng Hsu Breakdown of academic impact, for papers by Juri Kiyokawa Breakdown of academic impact, for papers by Akane Yamamichi
Rankless by CCL
2026